Shanghai Kaibao Pharmaceutical (300039): Kapitalflussrechnung
| Preis (11.09.2026) | 52W Hoch | 52W Tief |
| 5,07 Renminbi Yuan | 6,644 Renminbi Yuan | 4,02 Renminbi Yuan |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 7 Renminbi Yuan | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 1.046.000.000 | - | - |
Kennzahl in 1000 CNY | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Umsatz | 1.152.662,433 | 1.473.319,046 | 1.594.051,47 | 1.118.850,524 | 1.100.578,391 | 908.008,861 | 1.419.026,169 | 1.500.676,454 | 1.569.916,032 | 1.497.151,217 | 1.395.788,575 | 1.620.843,262 | 1.323.215,434 | 1.089.926,326 | 819.968,629 | 603.414,409 | 458.887,998 | 387.385,788 | 258.054,56 | 166.453,133 |
Cashflow aus operativer Geschäftstätigkeit | 230.741,218 | 278.950,298 | 382.664,972 | 376.418,583 | 126.078,156 | 250.649,879 | 334.085,296 | 262.361,43 | 245.758,441 | 314.879,061 | 327.081,937 | 282.378,515 | 270.234,671 | 243.323,767 | 98.307,48 | 19.787,855 | 52.738,056 | 18.695,182 | 23.270,708 | 19.697,437 |
▸ Operative Cashflow Marge | 20,02% | 18,93% | 24,01% | 33,64% | 11,46% | 27,6% | 23,54% | 17,48% | 15,65% | 21,03% | 23,43% | 17,42% | 20,42% | 22,32% | 11,99% | 3,28% | 11,49% | 4,83% | 9,02% | 11,83% |
Investitionsausgaben (CapEx) | 27.037,962 | 140.524,055 | 29.076,463 | 31.616,653 | 42.547,904 | 13.939,591 | 15.456,733 | 26.071,161 | 49.243,69 | 27.030,483 | 50.400,676 | 68.740,138 | 118.283,209 | 52.208,357 | 68.851,797 | 51.008,065 | 125.704,653 | 11.284,693 | 4.618,576 | 11.736,236 |
Cashflow aus Investitionstätigkeit | - | -33.428,757 | -198.630,956 | -285.373,359 | -83.507,643 | 65.213,934 | -600.752,212 | -174.041,816 | -221.909,008 | -435.321,348 | -105.269,766 | -208.740,138 | -168.283,209 | -52.148,357 | -65.497,178 | -51.008,065 | -125.699,007 | -13.153,679 | -4.605,576 | -11.736,236 |
Cashflow aus Finanzierungstätigkeit | - | -99.225,348 | -62.760 | -52.300 | -69.368,769 | -69.392,681 | -223.838,491 | -123.270,165 | -118.053,498 | -106.228,928 | -139.183,316 | -71.019,6 | -129.620 | -146.463,2 | -68.753,2 | -149.922,228 | 1.057.109,162 | 13.053,118 | -13.093,923 | -5.978,548 |
Freier Cashflow | 203.703,256 | 138.426,243 | 353.588,509 | 344.801,93 | 83.530,252 | 236.710,288 | 318.628,563 | 236.290,269 | 196.514,751 | 287.848,578 | 276.681,261 | 213.638,377 | 151.951,462 | 191.115,41 | 29.455,683 | -31.220,21 | -72.966,597 | 7.410,489 | 18.652,132 | 7.961,201 |
▸ Freie Cashflow Marge | 17,67% | 9,4% | 22,18% | 30,82% | 7,59% | 26,07% | 22,45% | 15,75% | 12,52% | 19,23% | 19,82% | 13,18% | 11,48% | 17,53% | 3,59% | -5,17% | -15,9% | 1,91% | 7,23% | 4,78% |
Ausgeschüttete Dividenden | -136.032,189 | -104.636,997 | -62.760 | -52.300 | -31.380 | -104.600 | -106.419,049 | -107.149,38 | -107.149,38 | -82.434 | -130.312,356 | -136.780,8 | -131.520 | -157.824 | -70.144 | -33.242,228 | -30.348,392 | -21.246,882 | -7.793,923 | -4.778,548 |
Neuausgabe und Rückkäufe von Stammaktien | - | - | - | - | - | - | -117.419,441 | - | -28.583,272 | -24.992,368 | - | - | - | - | - | - | - | - | - | - |
Kennzahlen dieser Seite im Lexikon
Weitere Informationen findest du im Takani-Lexikon.